Carlsmed Inc (CARL)

Currency in USD
11.72
-0.10(-0.85%)
Real-time Data·
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.3211.95
52 wk Range
8.5017.19
Key Statistics
Prev. Close
11.82
Open
11.68
Day's Range
11.32-11.95
52 wk Range
8.5-17.19
Volume
25.56K
Average Volume (3m)
172.66K
1-Year Change
-
Book Value / Share
3.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CARL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.60
Upside
+58.70%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Carlsmed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.60
(+58.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Needham
Buy17.00+44.56%-New Coverage01/07/2026
Truist Securities
Buy18.00+53.06%20.00Maintain15/04/2026
BTIG
Buy23.00+95.58%24.00Maintain13/04/2026
Goldman Sachs
Buy17.00+44.56%19.00Maintain09/04/2026
BTIG
Buy24.00+104.08%-Maintain15/12/2025

Carlsmed Inc Earnings Call Summary for Q1/2026

  • Carlsmed Q1 2026 revenue surged 58% YoY to $16.1M; gross margin improved 220 bps to 77.1% driven by surgeon adoption growth
  • Net loss widened to $8.7M from $5.7M as operating expenses jumped 62% to $21.7M, pressuring profitability despite revenue gains
  • Stock declined 2.31% to $9.09 in aftermarket trading, near 52-week low of $8.50; shares down 26% YTD amid investor expense concerns
  • Company maintains strong balance sheet with $97.1M cash; bilateral lumbar fusion platform launch scheduled for Q4 2026
  • Management projects continued revenue growth and improved adjusted EBITDA, targeting profitability through personalized surgery platform expansion
Last Updated: 05/05/2026, 22:20
Read Full Transcript

Earnings

Latest Release
05/05/2026
EPS / Forecast
-0.32 / -0.37
Revenue / Forecast
16.1M / --
EPS Revisions
Last 90 days

Compare CARL to Peers and Sector

Metrics to compare
CARL
Peers
Sector
Relationship
P/E Ratio
−9.8x−2.8x−0.4x
PEG Ratio
−0.13−0.330.00
Price/Book
3.5x4.9x2.6x
Price / LTM Sales
5.7x3.2x3.1x
Upside (Analyst Target)
52.3%54.0%50.8%
Fair Value Upside
Unlock13.7%7.8%Unlock

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.23M11.90%35.84M
Other Institutional Investors
24.62M88.10%272.73M
Public Companies & Retail Investors
0.000.00%0.00
Total
27.85M100.00%308.58M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
B Capital Group Management, L.P.30.61%8,321,76392,205
B Capital Global Growth III, L.P.18.44%5,013,83955,553

People Also Watch

12.25
AGMB
-0.57%
5.85
AARD
-7.58%
4.72
BTGO
-3.18%
1.125
AWRE
-2.17%

FAQ

What Is the Carlsmed (NASDAQ: CARL) Share Price Today?

The Carlsmed stock price today is 11.72 USD.

What Stock Exchange Does Carlsmed (CARL) Trade On?

Carlsmed is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Carlsmed?

The stock symbol (also called a 'ticker') for Carlsmed is "CARL."

What Is the Current Carlsmed Market Capitalisation?

As of today, Carlsmed (NASDAQ: CARL) market cap is 321.33M USD.

What Is Carlsmed's (CARL) Earnings Per Share (TTM)?

The Carlsmed EPS is currently -1.64 (Trailing Twelve Months).

When Is the Next Carlsmed Earnings Date?

Carlsmed's next earnings report will be released on 27/08/2026.

Is CARL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Carlsmed moving averages and other technical indicators, the daily buy/sell signal for CARL stock is Buy.

How Many Times Has Carlsmed Stock Split?

Carlsmed has split 0 times. (See the CARL stock split history page for full effective split date and price information.)

How Many Employees Does Carlsmed Have?

Carlsmed has 127 employees, based on their latest Companies House report.

What is the current trading status of Carlsmed (NASDAQ: CARL)?

As of 17/07/2026, Carlsmed (CARL) is trading at a share price of 11.72 USD, with a previous close of 11.82 USD. The stock has fluctuated within a day range of 11.32 USD to 11.95 USD, while its 52-week range spans from 8.50 USD to 17.19 USD.

What Is Carlsmed (CARL) Price Target According to Analysts?

The average 12-month price target for Carlsmed is 18.60 USD, with a high estimate of 23 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +58.70% Upside potential.

What Is the CARL Premarket Price?

CARL's last pre-market stock price is 11.85 USD. The pre-market share volume is 40.00, and the stock has decreased by 0.03, or 0.25%.

What Is the CARL After Hours Price?

CARL's last after hours stock price is 11.85 USD, the stock has decreased by 0.03, or 0.25%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.